Back
Oaktree Specialty Lending Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
43
OCSL
Oaktree Specialty Lending
Last Price:
19.23
Seasonality Move:
4.11%
Sell
38
ITCI
Intra-Cellular Therapies
Last Price:
66.97
Seasonality Move:
-6.93%
Sell
43
Oaktree Specialty Lending (OCSL)
is a Sell
Is Oaktree Specialty Lending a Buy, Sell or Hold?
- The current Oaktree Specialty Lending [OCSL] share price is $19.36. The Score for OCSL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- OCSL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $65.32. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OCSL Stock Price Chart
What is Oaktree Specialty Lending's stock price today?
-
The Oaktree Specialty Lending share price today is $19.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCSL is experiencing selling pressure, which indicates risk of future bearish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $65.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.
OCSL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 48.86 | Sell |
Chaikin Money Flow: | -329494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.22 - 19.64) | Sell |
Bollinger Bands (100): | (19.2 - 20.66) | Sell |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.32 | Sell |
Relative Strength Index (14 RSI): | 41.48 | Sell |
Chaikin Money Flow: | 421582 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.45 - 74.29) | Sell |
Bollinger Bands (100): | (65.99 - 72.19) | Sell |
OCSL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.33 | Buy |
20-day SMA: | 19.41 | Sell |
50-day SMA: | 19.42 | Sell |
200-day SMA: | 19.87 | Sell |
8-day EMA: | 19.34 | Buy |
20-day EMA: | 19.37 | Sell |
50-day EMA: | 19.5 | Sell |
200-day EMA: | 19.77 | Sell |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.78 | Sell |
20-day SMA: | 69.19 | Sell |
50-day SMA: | 68.67 | Sell |
200-day SMA: | 62.8 | Buy |
8-day EMA: | 66.34 | Sell |
20-day EMA: | 68 | Sell |
50-day EMA: | 68.71 | Sell |
200-day EMA: | 64.66 | Buy |
Oaktree Specialty Lending Earnings Growth & OCSL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.21 per share, and an increase next year of $0.03 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.
Oaktree Specialty Lending Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |